Hrt Financial LP X Biotech Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.03 - $8.13 $135,379 - $273,111	33,593 New	33,593 $273,000
Q4 2022 Feb 10, 2023	SELL	$3.03 - $3.79 $83,955 - $105,013	-27,708 Reduced 67.6%	13,279 $46,000
Q3 2022 Nov 14, 2022	SELL	$3.58 - $5.88 $68,789 - $112,984	-19,215 Reduced 31.92%	40,987 $148,000
Q2 2022 Aug 12, 2022	BUY	$5.13 - $9.2 $153,802 - $275,825	29,981 Added 99.21%	60,202 $338,000
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $117,538 - $159,302	-13,604 Reduced 31.04%	30,221 $261,000
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $87,391 - $128,254	7,981 Added 22.27%	43,825 $487,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $464,179 - $653,794	35,844 New	35,844 $464,000

4.67M

5.8K

4.6K

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $235M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.